These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32817933)

  • 1. Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry.
    Yuan Z; Pavel MA; Wang H; Hansen SB
    bioRxiv; 2020 Oct; ():. PubMed ID: 32817933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture.
    Yuan Z; Pavel MA; Wang H; Kwachukwu JC; Mediouni S; Jablonski JA; Nettles KW; Reddy CB; Valente ST; Hansen SB
    Commun Biol; 2022 Sep; 5(1):958. PubMed ID: 36104427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computational study on hydroxychloroquine binding to target proteins related to SARS-COV-2 infection.
    Navya VB; Hosur MV
    Inform Med Unlocked; 2021; 26():100714. PubMed ID: 34458558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings.
    Kalra RS; Tomar D; Meena AS; Kandimalla R
    Pathogens; 2020 Jul; 9(7):. PubMed ID: 32645974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19.
    Tichauer JE; Soto D; Andresen M
    Biomed Res Int; 2021; 2021():6614000. PubMed ID: 34337036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry.
    Palacios-Rápalo SN; De Jesús-González LA; Cordero-Rivera CD; Farfan-Morales CN; Osuna-Ramos JF; Martínez-Mier G; Quistián-Galván J; Muñoz-Pérez A; Bernal-Dolores V; Del Ángel RM; Reyes-Ruiz JM
    Front Immunol; 2021; 12():796855. PubMed ID: 34975904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral distinction between hydroxychloroquine enantiomers in binding to angiotensin-converting enzyme 2, the forward receptor of SARS-CoV-2.
    Aiello F; Balzano F; Uccello Barretta G; D'Acquarica I; Mazzoccanti G; Agranat I
    J Pharm Biomed Anal; 2024 Jan; 237():115770. PubMed ID: 37879140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid rafts are involved in SARS-CoV entry into Vero E6 cells.
    Lu Y; Liu DX; Tam JP
    Biochem Biophys Res Commun; 2008 May; 369(2):344-9. PubMed ID: 18279660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-Converting Enzyme 2 Potentiates SARS-CoV-2 Infection by Antagonizing Type I Interferon Induction and Its Down-Stream Signaling Pathway.
    Chen J; Liu J; Chen Z; Peng H; Zhu C; Feng D; Zhang S; Zhao P; Zhang X; Xu J
    mSphere; 2022 Aug; 7(4):e0021122. PubMed ID: 35862802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of high cholesterol in SARS-CoV-2 infectivity.
    Wang H; Yuan Z; Pavel MA; Jablonski SM; Jablonski J; Hobson R; Valente S; Reddy CB; Hansen SB
    J Biol Chem; 2023 Jun; 299(6):104763. PubMed ID: 37119851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine in COVID-19: Potential Mechanism of Action Against SARS-CoV-2.
    Satarker S; Ahuja T; Banerjee M; E VB; Dogra S; Agarwal T; Nampoothiri M
    Curr Pharmacol Rep; 2020; 6(5):203-211. PubMed ID: 32864299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chloroquine or hydroxychloroquine treatment on non-SARS-CoV2 viral infections: A systematic review of clinical studies.
    Cui X; Sun J; Minkove SJ; Li Y; Cooper D; Couse Z; Eichacker PQ; Torabi-Parizi P
    Rev Med Virol; 2021 Nov; 31(6):e2228. PubMed ID: 33694220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.
    Badraoui R; Adnan M; Bardakci F; Alreshidi MM
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33525415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.
    Klimke A; Hefner G; Will B; Voss U
    Med Hypotheses; 2020 Sep; 142():109783. PubMed ID: 32402766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZnO-chlorogenic acid nanostructured complex inhibits Covid-19 pathogenesis and increases hydroxychloroquine efficacy.
    Abomughaid MM; Nofal MS; Ghaleb KI; Seadawy MG; AbdEl-Wahab MG; Hegazy AS; Ghareeb DA
    J King Saud Univ Sci; 2022 Nov; 34(8):102296. PubMed ID: 36062198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations.
    Paniri A; Hosseini MM; Rasoulinejad A; Akhavan-Niaki H
    Eur J Pharmacol; 2020 Nov; 886():173454. PubMed ID: 32763298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
    Fantini J; Chahinian H; Yahi N
    Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.
    Gies V; Bekaddour N; Dieudonné Y; Guffroy A; Frenger Q; Gros F; Rodero MP; Herbeuval JP; Korganow AS
    Front Immunol; 2020; 11():1409. PubMed ID: 32714335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.